Uzbekistan hosts the 1st International Congress of Pediatric Oncology and Hematology “Evidence for Action”.

About 300 participants attended the event, including representatives of WHO, the International Society of Pediatric Oncology, the European School of Oncology, foreign university clinics and medical centers, international and national scientific circles, and civil society.

In recent years, the Head of state has personally paid great attention to the development of the healthcare sector in Uzbekistan. The country has implemented a phased separation of pediatric oncology and hematology from adult oncology. In 2022, the Center for Pediatric Hematology, Oncology and Clinical Immunology began operating in the capital. Measures have been taken to increase its human resources, strengthen its material and technical base, create favorable conditions for patients, and provide them with the necessary medicines.

The Congress, designed to become a platform for exchanging experience in solving these problems, was organized by the Ministry of Health and the Scientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology in collaboration with WHO, the International Society of Pediatric Oncology, and the European School of Oncology.

In her speech at the congress, Ziroat Mirziyoyeva noted: “We have gathered here with the sole purpose of overcoming one of the most serious diseases from which our children suffer. Every child has the right to life. We must use every opportunity to ensure that children are healthy and lead full lives in the future”.

The main goal of the three-day congress held in the capital is to discuss the latest scientific achievements and advanced diagnostic and treatment methods, establish international cooperation, improve the quality of medical care, and introduce advanced international and innovative practices in treating childhood cancer in Uzbekistan.

The Congress is a confirmation of the commitment and readiness of the Government of Uzbekistan to fulfill its obligations to achieve a 60% survival rate for children with cancer by 2030 as part of the WHO Global Initiative for Childhood Cancer.

During the congress, local specialists, together with foreign colleagues, will determine policy directions and effective interventions in the treatment of oncological, hematological, and immunological diseases in children. One of the event’s results will be the release and distribution of the congress’s collective declaration, “Incentive to Action”.

UzA